Good news for men—potentially—but bad news for patent librarians.
Millennium Predictive Medicine of Massachusetts has filed a patent (WO 01/60860)
on “novel genes” for identifying, assessing, preventing and treating prostate
cancer. It says the genes change as a patient develops prostate cancer, and so
provide an early warning of the disease. This should improve the chances for
therapy or surgery. But the gene sequences are so long that the patent fills 14
box files—equivalent to several hundred conventional paper patents.
More from New Scientist
Explore the latest news, articles and features
Technology
Quantum computers are starting to become useful as scientific tools
News
Technology
OpenAI’s hacking agent went rogue. Should we be worried?
News
Technology
China is trying to regulate relationships with AI – can it work?
News
Technology
The ancient Silk Road city that has a lesson for Silicon Valley
Comment
Popular articles
Trending New Scientist articles